T cell receptor

British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class…

Tempus, a leader in artificial intelligence and precision medicine announced a new collaboration to develop a companion diagnostic (CDx) test with…